A detailed history of Rothschild Investment LLC transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 35 shares of JANX stock, worth $1,903. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35
Previous 10 250.0%
Holding current value
$1,903
Previous $419,000 279.47%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$35.29 - $50.26 $882 - $1,256
25 Added 250.0%
35 $1.59 Million
Q2 2024

Jul 30, 2024

BUY
$35.12 - $64.78 $351 - $647
10 New
10 $419,000

Others Institutions Holding JANX

About Janux Therapeutics, Inc.


  • Ticker JANX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,663,000
  • Market Cap $2.27B
  • Description
  • Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...
More about JANX
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.